Skip to main content

A Stanford doctor who studied people who live to 110 on how humanity and AI will master aging

BioAge is developing treatments to extend healthy lifespan by targeting molecular causes of aging. Its CEO Kristen Fortney started by studying the super-old.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.